Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Antipsychotic APIs. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN109180577B introduces a superior Aripiprazole synthesis minimizing dimer impurities. Discover cost-effective manufacturing strategies for reliable API intermediate supply.
Patent CN110317182B reveals a novel Cariprazine preparation method. Achieve higher yields and reduced genotoxic impurities for reliable API supply chains.
Novel phthalimide route for brexpiprazole intermediate offers high purity and yield, significantly reducing costs for API manufacturers.
Patent CN115806510B reveals a cost-effective two-step synthesis for high-purity Cariprazine intermediates, offering significant supply chain advantages for API manufacturers.
Novel two-step route eliminates dimer byproducts, achieving >99% purity. Ideal for reliable API intermediate supply chains seeking cost reduction.
Advanced acid addition salt purification method for Olanzapine synthesis. Reduces coloration and dimer impurities for reliable pharmaceutical intermediate supply chains.
Patent CN101302195B reveals a solid-acid catalyzed synthesis for 7-Hydroxy-3,4-dihydroquinolone, offering high purity and reduced environmental impact for Aripiprazole manufacturing.